Genomics, PCR, COVID Testing, mRNA Vaccines, Blockchain Technology, Psilocybin Mushroom & Cannabis Genomes | Kevin McKernan | M&M #58

Mind & Matter

English - February 15, 2022 21:00 - 1 hour - 70.6 MB - ★★★★★ - 15 ratings
Science Society & Culture science drugs psychedelics technology biotechnology innovation biology brain neuroscience startups Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Alexandra Elbakyan: Sci-Hub, Open Data, Freedom of Information & the Democratization of Science | #57

Next Episode: CBD (Cannabidiol), Antiviral Drugs, SARS-CoV-2 & Cancer Biology | Marsha Rosner | #59

Kevin McKernan is a renowned leader in DNA sequencing technology. He led a research team part of the original Human Genome Project and is the founder and Chief Science Officer of Medicinal Genomics, a life sciences company that distributes genetics-based platforms for quality and safety testing of legal cannabis.

Nick and Kevin discussed the Cannabis genome, the genome of Psilocybe cubensis (magic mushrooms); Polymerase Chain Reaction (PCR) technology, how it works, and how it's used for COVID-19 testing; cannabinoids such as cannabidiol (CBD) and recent research indicating their potential anti-SARS-CoV-2 effects; blockchain technology for genomics data; and mRNA vaccines and SARS-CoV-2.

Support the show

Sign up for the free weekly Mind & Matter newsletter:
[https://mindandmatter.substack.com/?sort=top]

Learn how you can further support the podcast:
[https://mindandmatter.substack.com/p/how-to-support-mind-and-matter]